Clinical Trial

PROfunda Femoris Vein Thrombosis Evaluation and Clearance to Improve Outcomes of Endovascular Treatment for Acute Iliofemoral Deep Vein Thrombosis

Recruiting
View on ClinicalTrials.gov →
Summary
Patients with iliofemoral vein thrombosis are prone to developing post-thrombotic syndrome (PTS). The profunda femoris vein (PFV) is an important inflow of the iliofemoral vein. Profunda femoris vein thrombosis clearance (PFV-TC) may improve the patency of iliofemoral vein and reduce the occurrence of PTS.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-07-22
minor Completion pushed: 2029-07-30 -> 2029-12-31 2026-07-22
Trial Details
NCT Number NCT07622199
Lead Sponsor RenJi Hospital
Collaborators: Wenzhou Central Hospital, West China Hospital, Chengdu University of Traditional Chinese Medicine, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University, Changhai Hospital, First People's Hospital of Hangzhou
Conditions Deep Vein Thrombosis
Enrollment 140 participants
Start Date 2026-06-24
Primary Completion 2029-06-30 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-21